Drugs by condition
Drugs approved for opioid use disorder
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
6
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
0
New molecular entities and new biologics
In development
5
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for opioid use disorder.
- Brixadi (Buprenorphine) · Braeburn Priority reviewMay 23, 2023
- Sublocade (Buprenorphine) · Indivior Priority reviewOrphanNov 30, 2017
- Zubsolv (Buprenorphine Hydrochloride, Naloxone Hydrochloride) · Edenbridge Pharms Jul 3, 2013
- Suboxone (Buprenorphine Hydrochloride, Naloxone Hydrochloride) · Indivior OrphanAug 30, 2010
- Vivitrol (Naltrexone) · Alkermes Priority reviewApr 13, 2006
All approved drugs for opioid use disorder, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 29 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Partial Opioid Agonist (2)
Class not listed in FDA's data (4)
- Zubsolv Buprenorphine Hydrochloride, Naloxone Hydrochloride · Edenbridge Pharms · 2013
- Suboxone Buprenorphine Hydrochloride, Naloxone Hydrochloride · Indivior · 2010
- Vivitrol Naltrexone · Alkermes · 2006
- Methadone Hydrochloride Methadone Hydrochloride · Mylan Institutional · 1947
Drugs in development for opioid use disorder
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- CebranopadolTRN-228Phase 34 trials
Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain
- PEX010-Assisted TherapyPEX010Phase 22 trials
Filament Health Corp. · Stimulant Use Disorder, Opioid Use Disorder
- INDV-2000Phase 21 trial
Indivior Inc. · Opioid Use Disorder
- INDV-6001Phase 21 trial
Indivior Inc. · Moderate to Severe Opioid Use Disorder
More on opioid use disorder: recruiting trials · published research
Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Anxiety disorders · Insomnia · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.